These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23717017)

  • 21. Leukoderma induced by rhododendrol is different from leukoderma of vitiligo in pathogenesis: A novel comparative morphological study.
    Tsutsumi R; Sugita K; Abe Y; Hozumi Y; Suzuki T; Yamada N; Yoshida Y; Yamamoto O
    J Cutan Pathol; 2019 Feb; 46(2):123-129. PubMed ID: 30456919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal changes in active vitiligo.
    Hann SK; Park YK; Lee KG; Choi EH; Im S
    J Dermatol; 1992 Apr; 19(4):217-22. PubMed ID: 1607483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis).
    El-Darouti MA; Marzouk SA; Azzam O; Fawzi MM; Abdel-Halim MR; Zayed AA; Leheta TM
    Eur J Dermatol; 2006; 16(1):17-22. PubMed ID: 16436337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitiligo in Croatia: a case report.
    Bulat V; Situm M; Madiraca D; Majcen K; Dzapo A; Jezovita J
    Coll Antropol; 2014 Dec; 38(4):1191-4. PubMed ID: 25842755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired dermal melanocytosis on the hand of a pediatric patient.
    Marín-Hernández E; Marín-González EJ; Siordia-Reyes G
    Bol Med Hosp Infant Mex; 2019; 76(6):294-297. PubMed ID: 31769440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
    Kemp EH; Gavalas NG; Gawkrodger DJ; Weetman AP
    Autoimmun Rev; 2007 Jan; 6(3):138-42. PubMed ID: 17289548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
    Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
    Front Immunol; 2020; 11():624566. PubMed ID: 33613564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker.
    Kubanov A; Proshutinskaia D; Volnukhin V; Katunina O; Abramova T
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):5-9. PubMed ID: 27014772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of dermal melanocytosis with lysosomal storage disease: clinical features and hypotheses regarding pathogenesis.
    Hanson M; Lupski JR; Hicks J; Metry D
    Arch Dermatol; 2003 Jul; 139(7):916-20. PubMed ID: 12873889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired dermal melanocytosis of the hand: a new clinical type of dermal melanocytosis.
    Fukuda M; Kitajima J; Fushida H; Hamada T
    J Dermatol; 1993 Sep; 20(9):561-5. PubMed ID: 8227712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of non-melanocytic skin cells in vitiligo.
    Bastonini E; Bellei B; Filoni A; Kovacs D; Iacovelli P; Picardo M
    Exp Dermatol; 2019 Jun; 28(6):667-673. PubMed ID: 30582762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An unusual case of congenital dermal melanocytosis.
    Lee S; Kim DH; Lee G; Whang KU; Lee JS; Park YL
    Ann Dermatol; 2010 Nov; 22(4):460-2. PubMed ID: 21165221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the etiology of contact/occupational vitiligo.
    Boissy RE; Manga P
    Pigment Cell Res; 2004 Jun; 17(3):208-14. PubMed ID: 15140065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired symmetrical dermal melanocytosis (naevus of Hori) developing after aggravated atopic dermatitis.
    Murakami F; Soma Y; Mizoguchi M
    Br J Dermatol; 2005 May; 152(5):903-8. PubMed ID: 15888144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased expression of neuregulin1 in the lesional skin of vitiligo patients.
    Rani S; Kumari U; Bhardwaj S; Parsad D; Sharma VL; Kumar R
    Int J Dermatol; 2019 Feb; 58(2):242-249. PubMed ID: 30074619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitiligo and idiopathic guttate hypomelanosis. Repigmentation of skin following engraftment onto nude mice.
    Gilhar A; Pillar T; Eidelman S; Etzioni A
    Arch Dermatol; 1989 Oct; 125(10):1363-6. PubMed ID: 2508572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of auto antibodies and transplantation of cultured autologous melanocytes for the treatment of vitiligo.
    Zhu MC; Ma HY; Zhan Z; Liu CG; Luo W; Zhao G
    Exp Ther Med; 2017 Jan; 13(1):23-28. PubMed ID: 28123462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case Series With Acquired Dermal Melanocytosis: A Retrospective Study From 2001 to 2018.
    Hsiao PF; Chou W; Wu YH
    Am J Dermatopathol; 2022 Nov; 44(11):789-798. PubMed ID: 36240498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.